Metastatic breast cancer Clinical Trials in Olympia, WA
As of July 2026, 2 paid clinical trials are recruiting for Metastatic breast cancer in Olympia, Washington. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Olympia
Filter results
2 clinical trials for Metastatic breast cancer
·Clear filters·The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Top Research Study Locations in Olympia
Researchers run research studies in Olympia, WA at 16 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| American Oncology Network Vista Oncology Division | Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer | 3 |
| American Oncology Network Vista Oncology Division-East office | Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 3 |
| American Oncology Network Vista Oncology Division-West office | Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 3 |
| Vista Oncology | Breast Cancer, Carcinoma, Non-Small-Cell Lung, Diffuse Large B-Cell Lymphoma | 3 |
| Northwest Medical Specialties | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Metastatic Breast Cancer | 2 |
| Vista Oncology - East Olympia | Follicular Lymphoma (FL), Non-Small Cell Lung Cancer | 2 |
| Vista Oncology - East Olympia | Chronic Lymphocytic Leukemia, Non Small Cell Lung Carcinoma | 2 |
| American Oncology Network Vista Oncology Division / Physician partner associate | Multiple Myeloma (MM) | 1 |
| American Oncology Network Vista Oncology Division/Physician Partner Associate | Hepatocellular Carcinoma (HCC) | 1 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 1 |
| Home-based telemedicine | Chronic Granulomatous Disease (CGD) | 1 |
| Investigative | Solid Tumors | 1 |
| Olympia Pediatrics | Suicide Prevention | 1 |
| Olympia Surg Ctr | Lumbar Spinal Stenosis | 1 |
| Providence St. Peter Hospital | Central Line Associated Blood Stream Infections (CLABSI) | 1 |
| Vista Oncology Inc PS | Non-Small Cell Lung Cancer (NSCLC) | 1 |
Active & Upcoming Studies in Olympia (2026)
Recruiting trials in Olympia grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (20 active studies)
- A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma · Phase 1 · Shanghai Henlius Biotech
- Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 · Phase 3 · AstraZeneca
Cardiovascular (1 active study)
Common conditions studied in Olympia
- Breast Cancer (2 active studies)
- Carcinoma, Non-Small-Cell Lung (2 active studies)
- Gastric Cancer (2 active studies)
- Gastroesophageal Junction Adenocarcinoma (2 active studies)
- Metastatic Breast Cancer (2 active studies)
- Non-Small Cell Lung Cancer (2 active studies)
Leading research sponsors in Olympia
- Shanghai Henlius Biotech
- AbbVie
- American Society of Clinical Oncology
- AstraZeneca
- Pfizer
Frequently asked questions
How many paid clinical trials are currently recruiting in Olympia?
There are approximately 27 recruiting clinical trials in Olympia, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Olympia pay participants?
Most recruiting trials in Olympia compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Olympia?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Olympia?
The most common conditions under active study in Olympia include Breast Cancer (2), Carcinoma, Non-Small-Cell Lung (2), Gastric Cancer (2), Gastroesophageal Junction Adenocarcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Olympia?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Olympia on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Olympia?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Olympia?
Recruiting research sites in Olympia include American Oncology Network Vista Oncology Division, American Oncology Network Vista Oncology Division-East office, American Oncology Network Vista Oncology Division-West office, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Olympia right now?
The largest active categories in Olympia are Cancer & tumors (20), Cardiovascular (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.